Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2018

12.09.2017 | Epidemiology

Healthcare utilization, Medicare spending, and sources of patient distress identified during implementation of a lay navigation program for older patients with breast cancer

verfasst von: Gabrielle B. Rocque, Courtney P. Williams, Meredith I. Jones, Kelly M. Kenzik, Grant R. Williams, Andres Azuero, Bradford E. Jackson, Karina I. Halilova, Karen Meneses, Richard A. Taylor, Ed Partridge, Maria Pisu, Elizabeth A. Kvale

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Despite benefits for patients, sustainability of breast cancer navigation programs is challenging due to the lack of reimbursement for navigators. This analysis describes distress reported by breast cancer patients to navigators and the impact of navigation on healthcare utilization for older adults with breast cancer.

Methods

We conducted a retrospective cohort study of Medicare administrative claims data and patient-reported distress assessments. The primary outcome was Medicare spending per beneficiary per quarter. Secondary outcomes included (1) the number of hospitalizations or ER visits in each quarter; (2) distress levels; and (3) causes of distress reported by patients to their navigators. A subset analysis was conducted for stage I/II/III versus stage IV patients.

Results

776 navigated and 776 control patients were included in the analysis. The average age at diagnosis was 74 years; 13% of the subjects were African American; 95% of patients had stage I–III. Medicare spending declined faster for the navigated group than the matched comparison group by $528 per quarter per patient (95% CL −$667, −$388). Stage I/II/III navigated patients showed a statistically significant decline in Medicare spending, ER visits, and hospitalizations over time compared to the matched comparison group. No differences were observed for stage IV patients. Eighteen percent of patients reported moderate distress. Informational and physical distress were more common in late stage than in early-stage breast cancer.

Conclusions

Lay navigation reduced healthcare utilization in older adults with breast cancer, with the greatest impact observed in early-stage breast cancer patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Freeman HP (2006) Patient navigation: a community centered approach to reducing cancer mortality. J Cancer Educ 21(1 Suppl):S11–S14CrossRefPubMed Freeman HP (2006) Patient navigation: a community centered approach to reducing cancer mortality. J Cancer Educ 21(1 Suppl):S11–S14CrossRefPubMed
2.
Zurück zum Zitat Freeman HP (2013) The history, principles, and future of patient navigation: commentary. Semin Oncol Nurs 29(2):72–75CrossRefPubMed Freeman HP (2013) The history, principles, and future of patient navigation: commentary. Semin Oncol Nurs 29(2):72–75CrossRefPubMed
4.
Zurück zum Zitat Natale-Pereira A et al (2011) The role of patient navigators in eliminating health disparities. Cancer 117(15 Suppl):3543–3552PubMedPubMedCentral Natale-Pereira A et al (2011) The role of patient navigators in eliminating health disparities. Cancer 117(15 Suppl):3543–3552PubMedPubMedCentral
5.
Zurück zum Zitat Krok-Schoen JL et al (2015) Participants’ barriers to diagnostic resolution and factors associated with needing patient navigation. Cancer 121:2757CrossRefPubMedPubMedCentral Krok-Schoen JL et al (2015) Participants’ barriers to diagnostic resolution and factors associated with needing patient navigation. Cancer 121:2757CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Fouad M et al (2010) Patient navigation pilot project: results from the Community Health Advisors in Action Program (CHAAP). Ethn Dis 20(2):155–161PubMed Fouad M et al (2010) Patient navigation pilot project: results from the Community Health Advisors in Action Program (CHAAP). Ethn Dis 20(2):155–161PubMed
7.
Zurück zum Zitat Post DM et al (2015) Effects of patient navigation on patient satisfaction outcomes. J Cancer Educ 30(4):728–735CrossRefPubMed Post DM et al (2015) Effects of patient navigation on patient satisfaction outcomes. J Cancer Educ 30(4):728–735CrossRefPubMed
8.
Zurück zum Zitat Freund KM et al (2014) Impact of patient navigation on timely cancer care: the Patient Navigation Research Program. J Natl Cancer Inst 106(6):dju115CrossRefPubMedPubMedCentral Freund KM et al (2014) Impact of patient navigation on timely cancer care: the Patient Navigation Research Program. J Natl Cancer Inst 106(6):dju115CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Marshall JK et al (2015) Effect of patient navigation on breast cancer screening among African American Medicare Beneficiaries: a randomized controlled trial. J Gen Intern Med 31:68CrossRefPubMedPubMedCentral Marshall JK et al (2015) Effect of patient navigation on breast cancer screening among African American Medicare Beneficiaries: a randomized controlled trial. J Gen Intern Med 31:68CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Rocque GB et al (2016) Guiding Lay Navigation in Geriatric Patients With Cancer Using a Distress Assessment Tool. J Natl Compr Canc Netw 14(4):407–414CrossRefPubMed Rocque GB et al (2016) Guiding Lay Navigation in Geriatric Patients With Cancer Using a Distress Assessment Tool. J Natl Compr Canc Netw 14(4):407–414CrossRefPubMed
13.
Zurück zum Zitat Berenson RA, Horvath J (2003) Confronting the barriers to chronic care management in Medicare. Health Aff Suppl Web Exclusives: p. W3-37-53 Berenson RA, Horvath J (2003) Confronting the barriers to chronic care management in Medicare. Health Aff Suppl Web Exclusives: p. W3-37-53
14.
Zurück zum Zitat Wolff JL, Starfield B, Anderson G (2002) Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 162(20):2269–2276CrossRefPubMed Wolff JL, Starfield B, Anderson G (2002) Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 162(20):2269–2276CrossRefPubMed
15.
Zurück zum Zitat Coleman EA (2003) Falling through the cracks: challenges and opportunities for improving transitional care for persons with continuous complex care needs. J Am Geriatr Soc 51(4):549–555CrossRefPubMed Coleman EA (2003) Falling through the cracks: challenges and opportunities for improving transitional care for persons with continuous complex care needs. J Am Geriatr Soc 51(4):549–555CrossRefPubMed
16.
Zurück zum Zitat Mohile SG et al (2009) Association of a cancer diagnosis with vulnerability and frailty in older medicare beneficiaries. J Natl Cancer Inst 101(17):1206–1215CrossRefPubMedPubMedCentral Mohile SG et al (2009) Association of a cancer diagnosis with vulnerability and frailty in older medicare beneficiaries. J Natl Cancer Inst 101(17):1206–1215CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Rocque GB et al (2017) Resource use and medicare costs during lay navigation for geriatric patients with cancer. JAMA Oncol 3:817CrossRefPubMed Rocque GB et al (2017) Resource use and medicare costs during lay navigation for geriatric patients with cancer. JAMA Oncol 3:817CrossRefPubMed
18.
Zurück zum Zitat Colligan EM et al (2017) Innovative oncology care models improve end-of-life quality, reduce utilization and spending. Health Aff 36(3):433–440CrossRef Colligan EM et al (2017) Innovative oncology care models improve end-of-life quality, reduce utilization and spending. Health Aff 36(3):433–440CrossRef
19.
Zurück zum Zitat Rocque GB et al (2017) Implementation and impact of patient lay navigator-led advance care planning conversations. J Pain Symptom Manag 53(4):682–692CrossRef Rocque GB et al (2017) Implementation and impact of patient lay navigator-led advance care planning conversations. J Pain Symptom Manag 53(4):682–692CrossRef
21.
Zurück zum Zitat National Comprehensive Cancer Network, NCCN Guidelines: Distress Management (Version 2.2013) National Comprehensive Cancer Network, NCCN Guidelines: Distress Management (Version 2.2013)
22.
Zurück zum Zitat Vitek L, Rosenzweig MQ, Stollings S (2007) Distress in patients with cancer: definition, assessment, and suggested interventions. Clin J Oncol Nurs 11(3):413–418CrossRefPubMed Vitek L, Rosenzweig MQ, Stollings S (2007) Distress in patients with cancer: definition, assessment, and suggested interventions. Clin J Oncol Nurs 11(3):413–418CrossRefPubMed
23.
Zurück zum Zitat Mohile SG et al (2015) Geriatric assessment-guided care processes for older adults: a delphi consensus of geriatric oncology experts. J Natl Compr Cancer Netw 13(9):1120–1130CrossRef Mohile SG et al (2015) Geriatric assessment-guided care processes for older adults: a delphi consensus of geriatric oncology experts. J Natl Compr Cancer Netw 13(9):1120–1130CrossRef
24.
Zurück zum Zitat Wildiers H et al (2014) International society of geriatric oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 32:2595CrossRefPubMedPubMedCentral Wildiers H et al (2014) International society of geriatric oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 32:2595CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Klabunde CN et al (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258–1267CrossRefPubMed Klabunde CN et al (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258–1267CrossRefPubMed
26.
Zurück zum Zitat Charlson ME et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefPubMed Charlson ME et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefPubMed
27.
Zurück zum Zitat Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–619CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–619CrossRefPubMed
30.
Zurück zum Zitat Hassett MJ et al (2006) Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst 98(16):1108–1117CrossRefPubMed Hassett MJ et al (2006) Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst 98(16):1108–1117CrossRefPubMed
31.
Zurück zum Zitat Schilling MB, Parks C, Deeter RG (2011) Costs and outcomes associated with hospitalized cancer patients with neutropenic complications: a retrospective study. Exp Ther Med 2(5):859–866CrossRefPubMedPubMedCentral Schilling MB, Parks C, Deeter RG (2011) Costs and outcomes associated with hospitalized cancer patients with neutropenic complications: a retrospective study. Exp Ther Med 2(5):859–866CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Dulisse B et al (2013) A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia. J Med Econ 16(6):720–735CrossRefPubMed Dulisse B et al (2013) A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia. J Med Econ 16(6):720–735CrossRefPubMed
33.
Zurück zum Zitat Jolly TA et al (2015) Geriatric assessment-identified deficits in older cancer patients with normal performance status. Oncologist 20(4):379–385CrossRefPubMedPubMedCentral Jolly TA et al (2015) Geriatric assessment-identified deficits in older cancer patients with normal performance status. Oncologist 20(4):379–385CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Magnuson A et al (2016) Geriatric assessment with management in cancer care: current evidence and potential mechanisms for future research. J Geriatr Oncol 7(4):242–248CrossRefPubMedPubMedCentral Magnuson A et al (2016) Geriatric assessment with management in cancer care: current evidence and potential mechanisms for future research. J Geriatr Oncol 7(4):242–248CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Stanton AL et al (2015) Depressive episodes, symptoms, and trajectories in women recently diagnosed with breast cancer. Breast Cancer Res Treat 154(1):105–115CrossRefPubMed Stanton AL et al (2015) Depressive episodes, symptoms, and trajectories in women recently diagnosed with breast cancer. Breast Cancer Res Treat 154(1):105–115CrossRefPubMed
37.
Zurück zum Zitat Deckx L et al (2015) A cohort study on the evolution of psychosocial problems in older patients with breast or colorectal cancer: comparison with younger cancer patients and older primary care patients without cancer. BMC Geriatr 15:79CrossRefPubMedPubMedCentral Deckx L et al (2015) A cohort study on the evolution of psychosocial problems in older patients with breast or colorectal cancer: comparison with younger cancer patients and older primary care patients without cancer. BMC Geriatr 15:79CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Gabitova G, Burke NJ (2014) Improving healthcare empowerment through breast cancer patient navigation: a mixed methods evaluation in a safety-net setting. BMC Health Serv Res 14:407CrossRefPubMedPubMedCentral Gabitova G, Burke NJ (2014) Improving healthcare empowerment through breast cancer patient navigation: a mixed methods evaluation in a safety-net setting. BMC Health Serv Res 14:407CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Gunn CM et al (2014) An assessment of patient navigator activities in breast cancer patient navigation programs using a nine-principle framework. Health Serv Res 49(5):1555–1577CrossRefPubMedPubMedCentral Gunn CM et al (2014) An assessment of patient navigator activities in breast cancer patient navigation programs using a nine-principle framework. Health Serv Res 49(5):1555–1577CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Balducci L, Extermann M (2000) Management of cancer in the older person: a practical approach. Oncologist 5(3):224–237CrossRefPubMed Balducci L, Extermann M (2000) Management of cancer in the older person: a practical approach. Oncologist 5(3):224–237CrossRefPubMed
41.
Zurück zum Zitat Bluethmann SM, Mariotto AB, Rowland JH (2016) Anticipating the “Silver Tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomarkers Prev 25(7):1029–1036CrossRefPubMedPubMedCentral Bluethmann SM, Mariotto AB, Rowland JH (2016) Anticipating the “Silver Tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomarkers Prev 25(7):1029–1036CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Hanchate AD et al (2010) Longitudinal patterns in survival, comorbidity, healthcare utilization and quality of care among older women following breast cancer diagnosis. J Gen Intern Med 25(10):1045–1050CrossRefPubMedPubMedCentral Hanchate AD et al (2010) Longitudinal patterns in survival, comorbidity, healthcare utilization and quality of care among older women following breast cancer diagnosis. J Gen Intern Med 25(10):1045–1050CrossRefPubMedPubMedCentral
Metadaten
Titel
Healthcare utilization, Medicare spending, and sources of patient distress identified during implementation of a lay navigation program for older patients with breast cancer
verfasst von
Gabrielle B. Rocque
Courtney P. Williams
Meredith I. Jones
Kelly M. Kenzik
Grant R. Williams
Andres Azuero
Bradford E. Jackson
Karina I. Halilova
Karen Meneses
Richard A. Taylor
Ed Partridge
Maria Pisu
Elizabeth A. Kvale
Publikationsdatum
12.09.2017
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2018
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4498-8

Weitere Artikel der Ausgabe 1/2018

Breast Cancer Research and Treatment 1/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.